Drug Metabolism and Pharmacokinetic Services

Global Integrated Services for Discovery and Development 

As your Drug Metabolism and Pharmacokinetic (DMPK) partner, you have access to a global footprint with facilities in China (Shanghai, Suzhou and Nanjing) and the United States (New Jersey) offering a wide range of discovery screening, preclinical development and clinical DMPK platforms.

No matter where you are in the drug development continuum, we are here to ensure you meet your timelines and are committed to your drug development success. The WuXi AppTec DMPK team provides you with solutions tailored to your individual requests for your drug discovery and development needs.

Services and Quality

As part of our commitment to you, we provide a true end-to-end technical platform to seamlessly move your programs forward. Our DMPK team works closely with Chemistry, Biology and Pharmacology groups for either standalone or integrated services to support your compound’s design and selection during the drug discovery stage. 

Beyond Discovery, we provide Investigational New Drug (IND)-enabling and definitive Drug-Drug Interaction (DDI), Biotransformation and in vivo Absorption, Distribution, Metabolism and Excretion (ADME) study packages to support your drug development, in full compliance with international regulatory requirements.  Our DMPK team operates diligently with Toxicology, Regulatory Bioanalysis and the Clinical teams to ensure there’s a seamless handoff of data and insights. 

With over 15 years of experience, you can leverage our institutional knowledge, resources and expertise to help drive your discovery projects to IND and through to market.

Track Record of Success

WuXi AppTec’s DMPK team continues to support a diverse client base.  This comprises of more than 90% Large Pharma, over 600 small to mid-sized biopharma, virtual pharma, nonprofit organizations and academic institutions around the world. As you leverage the DMPK team’s experience and unprecedented efficiency, you will experience industry-leading turnaround times that accelerate your discovery and development programs. 

Global Clients

In vivo Studies per Year

In vitro Studies per Year

IND Programs in One Year

Operations and Compliance

To ensure exceptional quality across our laboratories, the DMPK team operates in accordance with global regulatory guidelines, and is fully accredited by AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care). Our scientific staff members come from accredited organizations and institutions. Staff members are involved in a rigorous and continuous training program to ensure site alignment and to drive forward WuXi AppTec’s reputation for quality and service.

  • 600+ Employees
  • 300+ Employees with PhDs / MS Degrees
  • Fully Accredited with AAALAC
  • Compliant with U.S. Food and Drug Administration, (FDA), European Medical Agency (EMA), Environmental Protection Agency (EPA), National Medical Products Administration (NMPA), U.S. Department of Agriculture (USDA) and the Drug Enforcement Administration (DEA) regulations
  • Office of Laboratory Animal Welfare (OLAW) Assurance to Conduct Public Health Service (PHS) funded studies